Imprimis Pharmaceuticals Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary compounded drug therapies, has made available a customizable compounded formulation of pyrimethamine and leucovorin available for physicians to consider prescribing for their patients as a low cost alternative to Daraprim. Last month, Turing Pharmaceuticals LLC, the sole supplier of Daraprim, increased the price of this prescription drug from $13.50 per tablet to a r...